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doi:10.1016/j.kjms.2011.05.011Abstract This study based on the synthesis, characterization, and structural calculation of
small molecular potassium-encapsulated arsenic-dithiolato compounds will provide funda-
mental knowledge about arsenic metabolism behavior in biological system. Two novel air-
stable potassium-encapsulated arsenic-dithiolato compounds, [K@As2(L1)3](BF4) (1) and
[K@As2(L2)3](BF4) (2), were prepared using deprotonated 2,6-bis(mercaptomethyl)pyridine
(L1H2) and 1,3-dimercapto-m-xylene (L2H2) to react with AsCl3 in the presence of potassium
cation. Compounds 1 and 2 have been characterized by electrospray ionization-mass spectra,
nuclear magnetic resonance spectra, and elemental microanalysis. Density functional theory
calculation also supports the formation and binding properties of the potassium-encapsulated
arsenic-dithiolato compounds.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Arsenic is one of the most toxic inorganic ions. It is also
a natural contaminant of water supplies in global environ-
mental problem because arsenic can enter groundwater
systems from weathering and leaching of arsenic mineralst of Medicinal and Applied
ity, 100 Shi-Chuan 1st Road,
an.
.tw (S.C.N. Hsu).
vier Taiwan LLC. All rights reservin rock and soil [1,2]. Compounds of arsenic found in the
environment are broadly classified as either organic or
inorganic with two common oxidation states of 3þ and 5þ.
Studies on the toxicity of arsenic ion shows that there are
two forms of arsenic: one is arsenate (AsV; HAsO4
2) and the
other is arsenite [AsIII; As(OH)3] [3]. When arsenate is
imported into cells by the anion transport pathway, it
disrupts cellular processes by mimicking as phosphate. The
arsenate may reduce to arsenite by thiol-rich proteins
within cells, which is shown by numerous literature studies
[4]. Usually, proteins undergo a critical conformational
change on binding AsIII with two or three cysteine residuesed.
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thiol residues, which may form a three-coordination AsIII
compound [7e10], is more toxic than arsenate and has been
shown to disrupt the activity of certain enzymes, such as
pyruvate dehydrogenase [11,12], glutathione reductase
[13], and thioredoxin reductase [14].
From the chemistry point of view, the monothiols bind
arsenicals rather weakly, although the relatively high
intracellular concentration of free glutathione will strongly
influence arsenic speciation in mammalian cells. In
contrast, protein dithiols bind monoalkyl or monoaryl AsIII
species much more tightly by means of the chelating effect
[9,15]. Indeed, many of the suggested protein targets of
arsenicals have dithiols or trithiols in close proximity
[16e19]. Despite arsenic’s biological precedence and
implications on health, there is relatively little structural
detail known about its interactions with proteins and also
still remains a general lack of small-molecule AsIII compounds
in biological coordination environments [20e25]. In this
study, we synthesized two types of dithiolate ligands 2,6-
bis(mercaptomethyl)pyridine (L1H2) and 1,3-dimercapto-m-
xylene (L2H2) to imitate the protein cysteine residues that
react with the arsenic ion as structural biomimicking models.
These studies on the synthesis and characterization of simple
potassium-encapsulated arsenic-dithiolato compounds will
provide fundamental knowledge about arsenic metabolism
behavior in biological system.
Materials and methods
General considerations
All manipulations were carried out in an atmosphere of
purified dinitrogen with standard Schlenk techniques.
Chemical reagents were purchased from Aldrich Chemical
Company Ltd., Lancaster Chemicals Ltd., or Fluka Ltd. All
the reagents were used without further purification, apart
from all solvents that were dried over Na (Et2O, tetrahy-
drofuran; THF) or CaH2 (CH2Cl2, CH3CN) and then thor-
oughly degassed before use. 2,6-Bis(mercaptomethyl)
pyridine (L1H2) [26] and 1,3-dimercapto-m-xylene (L2H2)
[27] were prepared according to the literature procedures.
1H nuclear magnetic resonance (NMR) and 13C NMR spectra
were acquired on a Varian Gemini-200 proton/Carbon FT
NMR or a Varian Gemini-500 proton/Carbon FT NMR spec-
trometer. Electrospray ionization (ESI)-mass spectra were
collected on a Waters ZQ 4000 mass spectrometer.
Elemental analyses were performed on a Heraeus CHN-OS
Rapid Elemental Analyzer.
Synthesis of [K@As2(L1)3](BF4) (1)
2,6-Bis(mercaptomethyl)pyridine (L1H2; 0.70 mmol, 120 mg)
was added to a solution of THF (50 mL) and KOH (2.14 mmol,
120 mg) in CH3OH (20 mL). This solution was heated to 50
C,
and AsCl3 (0.50 mmol, 90 mg) was added dropwise. The
reaction mixture was stirred at room temperature for 3
hours and dried in vacuo to give a white solid. The white
solid was extracted by CH3CN (15 mL 3), and then, KBF4
(0.24 mmol, 30 mg) in CH3CN (10 mL) was added into the
extract to give a white precipitate. The resulting whiteprecipitate was removed by filtration, and the filtrate was
dried in vacuo (yield, 136 mg; 75%). 1H NMR spectra (DMSO)-
d6): d 3.70 (s, 4H, Py-CH2-S); 7.01 (d, 2H, Py-H); 7.49 (t, 1H,
Py-H ). 13C{1H} NMR (DMSO-d6): d 38.63 (Py-CH2-S), 120.53
(Py), 136.63 (Py), 161.66 (Py). ESI-mass spectra: 695.70
[K@As2(C7H7NS2)3]
þ. Anal. Calcd. for C21H21As2BF4KN3S6: C,
32.19; H, 2.70; N, 5.36. Found: C, 32.22; H, 2.72; N, 5.32.
Synthesis of [K@As2(L2)3](BF4) (2)
1,3-Dimercapto-m-xylene (L2H2; 0.66 mmol, 112 mg) was
added to a solution of THF (50 mL) and KOH (1.96 mmol,
110 mg) in CH3OH (15 mL). This solution was heated to
50C, and AsCl3 (0.44 mmol, 80 mg) was added dropwise.
The reaction mixture was stirred at room temperature for 3
hours and dried in vacuo to give a white solid. The white
solid was extracted by CH3CN (15 mL 3), and then, KBF4
(0.24 mmol, 30 mg) in CH3CN (10 mL) was added into the
extract to give a white precipitate. The resulting white
precipitate was removed by filtration, and the filtrate
was dried in vacuo (yield, 108 mg; 63%). 1H NMR spectra
(DMSO-d6): d 3.82 (s, 4H, Ph-CH2-S); 7.10 (s, 1H, Ph-H); 7.21
(d, 2H, Ph-H); 7.43 (t, 1H, Ph-H ). 13C{1H} NMR spectra
(DMSO-d6): d 25.43 (Ph-CH2-S), 126.15 (Ph), 128.73 (Ph),
130.05 (Ph), 139.66 (Ph). ESI-mass spectra: 692.71
[K@As2(C8H8S2)3]
þ. Anal. Calcd. for C24H24As2BF4KS6: C,
36.93; H, 3.10. Found: C, 37.01; H, 3.15.
Computational methods
Density functional theory (DFT) calculations of B3LYP/
LANL2DZ level were used to provide the information
regarding the structure, binding energy, and charge
distribution of Compounds 1 and 2. Geometry optimiza-
tions with C3h constraint were carried out for compounds
containing potassium cation, whereas no symmetric
constraint (i.e. C1 symmetry) was imposed to geometry
optimization calculations for complexes without potassium
cation. Frequency calculations were performed to confirm
that all the optimized structures were indeed a local
minimum on the potential energy surface. The charge
distributions were analyzed by using the Mulliken pop-
ulation analysis. The binding energy of Kþ was estimated
by the energetic difference between the total energy of
potassium-contained complex and that of free complex
and Kþ. All calculations were accomplished by Gaussian 09
program [28].
Results and discussion
The dithiolate ligands 2,6-bis(mercaptomethyl)pyridine
(L1H2) and 1,3-dimercapto-m-xylene (L2H2) are synthe-
sized by literature procedure [26,27]. When a pale yellow
THF solution of a L12 or L22 (deprotonated with 2 mol
equiv. of sodium methyloxide) was treated with 0.33 mol
equiv. of AsCl3, an insoluble yellow precipitate immedi-
ately formed, which is proposed to be a polymer of formula
As2L3 (LZ L1
2 or L22); this was proved by elemental
analyses. However, if potassium salt agents (potassium
methyloxide or potassium hydride) are used in the depro-
tonation process, a potassium-encapsulated cationic
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Figure 1. Representation synthesis of Compounds 1 and 2.
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þ
[LZ L12 (1); L22 (2)], which can be confirmed by ESI-
mass technique. ESI is a very mild ionization technique
with minimum perturbations of the species presented in
solution and have been performed on the monitoring
reaction processes [29e31].
To give more information about the formation of
cationic dimer compounds [K@As2(L1)3]
þ (1) and
[K@As2(L2)3]
þ (2) in presence of potassium cation, we also
examined the reaction of dithiol ligands (L1H2 or L2H2) with
stoichiometric amounts of AsCl3 and KOH in THF/methanol
mixtures (Fig. 1). In the KOH assistance, cationic products 1
and 2 are formed and characterized by ESI-mass spectra.
Both cationic compounds 1 and 2 contain three dithiolatoFigure 2. Calculated (A and B) and experimental (C and D) electro
cationic diarsenic compounds 1 (A and C) and 2 (B and D).ligands and incorporate with one potassium cation, which
can be confirmed by their formula by well-resolved ESI-
mass spectra with the pattern of molecular ion peaks
(Fig. 2), respectively. On the other hand, NaOH is a substi-
tute for KOH during the reaction; however, only insoluble
yellow precipitates present. This indicates that only
potassium can assist cationic diarsenic compounds 1 and 2
formation. Additionally, the very simple 1H and 13C NMR
data of 1 and 2 also suggest the high-symmetry C3h struc-
ture and the absence of any rapid equilibration between
the dithiolato chelate rings. This profile indicates the
molecular structure of the cation core of 1 and 2, because
the nature of chelation to potassium cation and AsIII atom
results in the ligands being equivalent to each other.
When methanol solutions of 1 or 2 are purged with air or
O2(g) for 5 minutes, no significant change in the ESI-mass
and 1H NMR spectra are observed over 1 hour. From this
observation, compounds 1 and 2 demonstrate remarkable
stability under aerobic conditions, suggesting that these
potassium cation-assistance self-assembled compounds are
not only kinetic products but also, indeed, the thermody-
namic products of the reaction between arsenic and
dithiolato ligands. There was no ligand exchange between 1
and L22 ligand on the ESI-mass monitoring and vice versa.
Compounds 1 and 2 also were robust to a variety of
competing metal ions, such as Na(I), Ag(I), Cu(I), Fe(II), and
Zn(II).
Hsu and Boyer et al. have shown that alkali catione
templated cage formation is controlled by the radius ofspray ionization-mass spectrum of the potassium-encapsulated
Figure 3. Molecular structure of the cations of compounds 1 (A) and 2 (B) in density functional theory calculation results at the
50% level.
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serve as an essential template for a larger cage compared
with the sodium cation for small cage formation. In our case,
the formation of potassium-encapsulated cationic diarsenic
compounds 1 and 2 may be assisted and controlled by the
size of templated cation. To provide insights into the
properties of compounds 1 and 2, DFT of B3LYP/LANL2DZ
method was used to locate the optimized structures and to
evaluate the binding energies of dithiolato ligands with Kþ.
The DFT geometry optimizations revealed several inter-
esting structural features for compounds 1 and 2 (Figs. 3 and
4). Both compounds have similar structural features and are
characterized by a cage structure formed by the three
dithiolato ligands and two arsenicals through SeAs interac-
tions with a potassium cation located in the center of the
cage. The arsenicals are situated outward the cage and,
therefore, have no contribution to the binding with potas-
sium cation. Instead, the embedded potassium cation is
stabilized by six SeKþ interactions. Furthermore, the
aromatic rings of the ligands use their face rather than edge
pointing toward the interior of the cage; for compound 1,Figure 4. Pseudo-threefold views of the cations of compounds 1
the 50% level.the nitrogen atom of pyridine ring is nearest to Kþ with
a distance of 3.21 A˚, whereas for compound 2, the shortest
contact between benzene ring and Kþ is 3.40 A˚ (Table 1). It
is worth to notice that the cavity size of compound 2 is
somewhat larger than that of compound 1, which can be
evidenced from the longer distances of SeKþ and ringeKþ
contacts in the former than in the latter (Table 1). The
effect of cavity size truly reflects on the binding ability to
potassium cation; the theoretical estimate of binding
energy of Kþ is 53.7 kcal/mol for compound 1, remarkably
greater than45.6 kcal/mole for compound 2. The Mulliken
population analysis indicated that the chargeetransfer
interaction should play a role in stabilizing the potassium
cation; note that Kþ bears only 0.67 jej positive charge
(Table 2); in other words, about 0.33 jej negative charge is
transferred from the ligands to potassium.
Herein, we have synthesized and characterized the
potassium-encapsulated cationic diarsenic compounds 1
and 2. Further investigation of DFT calculation shows that
potassium-encapsulation ability is affected by the cavity
size of arsenic-dithiolato-based capsules. It is well known(A) and 2 (B) in density functional theory calculation results at
Table 1 Selected B3LYP/LANL2DZ optimized distances (A˚)
of compounds 1 and 2
Compound Distance (A˚)
1
S to As 2.44
S to K 3.31
N to K 3.21
As to As 7.72
2
S to As 2.44
S to K 3.39
C to K 3.40
As to As 7.84
Table 2 Mulliken atomic charges for compounds 1 and 2
Compound 1 Compound 2
As 0.420 0.453
K 0.673 0.675
S 0.142 0.179
428 S.C.N. Hsu et al.that trivalent arsenic can bind to cysteine residues of
proteins [4,33]. L12 and L22 display simultaneous SNS and
SS interaction for cysteine and histidine units of protein,
which may interact with AsIII and encapsulate potassium
cation in biological system. There are not many good bio-
logically relevant models of arsenic compounds in biological
coordination environments, it is the first time that potas-
sium-encapsulation behavior by the chelated dithiolate
ligands cooperated with arsenic system is observed; this
finding may provide fundamental clue to construct Asebase
chemosensors, which is in progress in studies in our
laboratory.
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